Stocks · News reference
Oppenheimer Reiterates Outperform on Xylem, Lowers Price Target to $150
Oppenheimer analyst Bryan Blair reiterates Xylem (NYSE:XYL) with a Outperform and lowers the price target from $158 to $150.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
North America Single Stage Centrifugal Pumps Market Size, Share, Growth Opportunities, and Forecast 2026-2035 | Smart, Energy-Efficient Systems Drive Market to USD 9 Billion
The North America single stage centrifugal pumps market is valued at USD 5.9 billion in 2025 and is projected to reach USD 9 billion by 2035, growing at a CAGR of 4.3%. Market expansion is driven by industrial modernization, energy-efficient equipment demand, and smart monitoring technologies. Horizontal and stationary pump systems dominate the market, with the U.S. accounting for 77% of regional revenue.
RBC Capital Maintains Outperform on Xylem, Lowers Price Target to $135
RBC Capital analyst Jeffrey Reive maintains Xylem (NYSE:XYL) with a Outperform and lowers the price target from $164 to $135.